Cantitate/Preț
Produs

Cardiomyopathies and Heart Failure: Biomolecular, Infectious and Immune Mechanisms: Developments in Cardiovascular Medicine, cartea 248

Editat de Akira Matsumori
en Limba Engleză Paperback – 13 oct 2012
Descriere de la o altă ediție sau format:
Comprises an account of existing knowledge on the subject of cardiomyopathy and heart failure. This volume covers various major investigational and clinical aspects of the topic. It provides syntheses as well as reviews, offering a multidisciplinary and international perspective. It is targeted towards practicing physicians and basic researchers.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 139506 lei  6-8 săpt.
  Springer Us – 13 oct 2012 139506 lei  6-8 săpt.
Hardback (1) 191367 lei  6-8 săpt.
  Springer Us – 31 iul 2003 191367 lei  6-8 săpt.

Din seria Developments in Cardiovascular Medicine

Preț: 139506 lei

Preț vechi: 146849 lei
-5% Nou

Puncte Express: 2093

Preț estimativ în valută:
26707 27761$ 22143£

Carte tipărită la comandă

Livrare economică 05-19 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781461348658
ISBN-10: 146134865X
Pagini: 556
Ilustrații: XXI, 531 p.
Dimensiuni: 155 x 235 x 29 mm
Greutate: 0.77 kg
Ediția:Softcover reprint of the original 1st ed. 2003
Editura: Springer Us
Colecția Springer
Seria Developments in Cardiovascular Medicine

Locul publicării:New York, NY, United States

Public țintă

Professional/practitioner

Cuprins

Cardiomyopathies and Heart Failure: Biomolecular, Infectious and Immune Mechanisms.- 1. Chemokines and Cardiovascular Diseases.- 2. Negative Regulator of Cytokine Signaling (SOCS) Genes in Inflammation.- 3. The Interleukin-6 Family of Cytokines and their Receptors in Patients with Congestive Heart Failure.- 4. Animal Model of Cardiomyopathy Due to Overexpression of TNF-?.- 5. Myosin Autoreactive T Cells and Autoimmune Myocarditis: Lessons from the Disease Caused by Cardiac Myosin Peptide CM2.- 6. Autoimmunity in Cardiomyopathies.- 7. Anti-G-Protein Coupled Cardiac Receptor Autoantibodies In Dilated Cardiomyopathy.- 8. Clinical Significance of Circulating Cardiac Autoantibodies in Dilated Cardiomyopathy and Myocarditis.- 9. Development of Mast Cells: Process and Regulatory Mechanisms.- 10. Mast Cells in Experimental Myocardial Infarction.- 11. Possible Involvement of Mast Cells in the Development of Fibrosis.- 12. Human Mast Cell Chymase and 31 Amino Acid Endothelin-1.- 13. Tryptase From Human Mast Cells.- 14. Effects of the Tryptase Receptor Activating Peptide and Antibodies Against the Tryptase Receptor Par-2 On Neonatal Rat Cardiomyocytes in Culture.- 15. Role of Human Heart Mast Cells in Immunologic and Inflammatory Mechanisms Underlying Cardiovascular Disorders.- 16. Mast Cells in Atherosclerotic Human Coronary Arteries: Implications for Coronary Fatty Streak Formation and Plaque Erosion or Rupture.- 17. The Key Role of Mast Cells in the Evolution to Congestive Heart Failure.- 18. Links Between Viral Infections And Heart Disease.- 19. Molecular Detection and Characterization of Human Enteroviruses.- 20. Detection and Biological Implications of Genetic Memory in Viral Quasispecies.- 21. The Group B Coxsackieviruses as Vaccines and Vectors.- 22. Detection ofImportant Diagnostic Markers of HCV Infection.- 23. Large Animal Model of Viral Myocarditis.- 24. Hepatitis C Virus and Cardiomyopathy.- 25. Diagnosis and Treatment of Myocarditis: The Role of Adenovirus Infection in Cardiomyopathy and Heart Failure.- 26. The Natural History of Viral Myocarditis: Pathogenetic Role of Adrenergic System Dysfunction in the Development of Idiopathic Dilated Cardiomyopathy.- 27. Clinical Diagnosis of Myocarditis.- 28. Recent Advances in Giant Cell Myocarditis.- 29. Registry of Myocarditis and Heart Failure.- 30. Molecular Etiology of Idiopathic Cardiomyopathy.- 31. Gene-Based Therapy of Long QT Syndrome.- 32. How Does Adenosine Mediate Cardioprotection?.- 33. Protection of Cell Injury by Thioredoxin.- 34. Hematopoietic Stem Cells and Angiogenesis.- 35. Transplanting Cells for the Treatment of Cardiomyopathy.- 36. Toward an Ideal Large Animal Model Of Dilated Cardiomyopathy to Study Left Ventricular Volume Reduction Surgery.- 37. Heart Transplantation: 35 Years of Progress.- 38. Genes of the Major Histocompability Complex Class II Influence The Phenotype Of Cardiomyopathies Associated With Hepatitis C Virus Infection.